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Abstract 
The primary use of the traditional candidate gene approach over the past decades in 
sports genetics has had limited success in identifying genes associated with elite athletic 
performance. Advances in high-throughput technologies now permit the application of 
“omics” (e.g. genomics, transcriptomics, metabolomics, proteomics and epigenomics) 
approaches to examine the global features of a cell, tissue or organism. 
“Omics” approaches are being applied with some success to a wide range of pertinent 
biomedical problems such as cancer diagnosis but also in sports science and sports 
medicine such as for the identification of biomarkers of trainability or blood doping. 
There is good evidence to suggest that a combined “omics” solution will greatly 
facilitate discovery of the genetic influences on sporting performance, training response, 
injury predisposition and other potential determinants of successful human performance. 
In this regard, large-scale, collaborative efforts involving well-phenotyped cohorts will 
be essential for major progress to be made. A recent consensus emerged among 15 
research groups active in the field of sports genetics to unite their efforts under one new 
collaborative initiative named the Athlome Project Consortium. The primary aim of the 
Athlome Project is to combine resources from individual studies and consortia 
worldwide to collectively study the genotype and phenotype data available on elite 
athletes, the adaptation to exercise training (in both human and animal models) and the 
determinants of exercise-related musculoskeletal injuries. This editorial summarizes the 
challenges and opportunities facing the Athlome Project Consortium and the field of 
sports and exercise genomics in general. 
Rare versus common variant hypothesis and the dilemma of rare phenotypes 
There is much interest in the fact that athletes dominating certain sports originate from 
specific geographical areas for instance, endurance runners from Ethiopia or Kenya 
(East Africa), sprinters from Jamaica or USA (West Africa), and gymnasts and figure 
skaters from Japan, Korea, or China (Far East Asia). Although these occurrences are 
more likely a reflection of historic socioeconomic and cultural characteristics of each 
location, it is presumed that the area-specific segregation of sports performance is based 
on uneven distribution of the genetic characteristics that relate to the physical and 
metabolic properties of individuals in each area (see (8)). 
  
In recent decades, genetic approaches in sports and exercise science have primarily 
focused on the candidate gene approach, with some attempts of applying the 
genome-wide association study (GWAS). Despite these efforts, there has been little 
progress in identifying genes that are locally or universally linked with athletic 
performance, with the likely exceptions the variants in the ACTN3 and ACE genes 
(1,11). Each of the common single nucleotide polymorphisms (SNPs) usually has only a 
small functional effect, thus initially resulted in the development of the genomic score 
approach that sums up the numbers of alleles of potential influential SNPs to predict 
performance (17), training response (2), or risk of obesity, hyperlipidemia, or 
hyperglycemia with reference to the effect of physical fitness (14-16). The genetic score 
approach usually exhibits a Gaussian distribution, and although the very best athletes 
score higher, their extreme performances cannot be adequately explained by the 
summation of common SNPs with small effects (3). Based on the current literature, it is 
reasonable to hypothesize that the rare and extreme phenotypes of elite athletes can be 
explained by rare functional variations or mutations that emerged and were selected 
rather recently in human history, so that these SNPs or mutations are detectable only in 
some global regions. This notion is similar to the idea that is used for the discovery of 
inherited diseases caused by mutations in single or multiple genes (18). Shifting the 
preferred approach from the candidate gene approach to the genome-wide association 
study resulted in the emergence of the multi-comparison problem where the Bonferroni 
correction or the conventional genome-wide significance threshold of 5 x 10-8 in 
European populations or 1 x 10-8 in African populations (13) needed to be overcome. If 
the target region is expanded to include the whole genome of 3 x 109 base pairs, and 
assuming the frequency of sequence variations in our genome is about 1 out of 1000 
bases, each individual is likely to have 3 x 106 variations in their genome. Consequently, 
identifying a SNP or structural variation linked with an extreme phenotype would be 
exceedingly difficult even if hundreds or thousands of DNA samples were collected 
from elite athletes. This is the major problem facing sports and exercise genomics. It is 
likely that the rare SNPs are more region-specific and emerged more recently in the 
history of human evolution than the common SNPs. Other views include the notion that 
the capacity for endurance running is a newly acquired common phenotype of all 
modern humans (4,12). It is unknown at the moment whether the extreme phenotypes of 
elite athletes are ascribable to a limited number of rare variants or to high combinations 
of common variants. To discover the secret of the genomes of elite athletes will require 
a dedicated international collaborative efforts such as the newly formed Athlome Project 
Consortium that was founded as a result of a symposium held in Athens and on the 
Greek island of Santorini from 14-17th May 2015. The purpose of the Santorini meeting 
was to review the main findings in exercise genetics and genomics and to explore 
promising trends and possibilities.  
New era of whole genome sequencing and future directions 
A detailed analysis of the genome reveals unexpected findings in the genome data of 
each individual such as a few hundred disease-causing mutations. It is recommended 
that researchers involved in whole genome sequencing report mutations in the list of 
genes that are considered linked with inherited diseases. Not all individuals are 
symptomatic of disease and many will never experience any symptoms during their 
entire life (The MedSeq Project, (9)). Whole genome analysis of elite athletes is going 
to reshape our current understanding of the genetic basis of human performance and by 
association heath-related fitness. This knowledge will help generate new solutions to 
modern-day health problems such as inactivity, obesity and sarcopenia; all of which are 
at the opposite spectrum of the elite athlete phenotype. 
 
In order to facilitate maximum progress recent developments in information technology 
that guarantee both the safety of unique genetic information of individual athletes as 
well as the ease of access for researchers exploring links between genotypes and 
phenotypes must be applied. Vital lessons are already being learned from the field of 
cancer genomics. For example, in the COSMIC catalogue storing the somatic mutation 
information (5,7), the somatic mutations in the cancer tissues and the germ line 
variations are analyzed but only the somatic mutations present in the cancer tissue are 
open access. Data generated from the Athlome Project Consortium will be made 
publically available for sharing of resources with the wider scientific community 
(http://staging.athlomeconsortium.org/), particularly when whole genome sequencing of 
hundreds of elite athletes takes place, as is currently planned (e.g. 1000 Athlomes 
project (10) in this series). Whole genome sequencing studies of elite athletes alone will 
not, however, be sufficient to meaningfully understand the mechanisms underlying the 
extreme athlete phenotype. This will require genomic and epigenomic information that 
can be potentially linked with transcriptomic and proteomic information (e.g. (6) paper 
by Durussel et al. in this series). Establishing lymphocyte or myocyte clones isolated 
from elite athletes will also be important in this regard as the transcriptome or proteome 
data from such resources are less affected by environmental conditions including 
exercise training or unknown doping.  
This issue of Physiological Genomics is a pivotal landmark in the field of sports and 
exercise genomics, contributed by the participants of the Santorini Conference 2015 that 
abridges the current literature and the future trends in sports and exercise science and 
medicine. This series of manuscripts will be a useful resource for scientists, researchers, 
students and others who have an interest in genetics, genomics and exercise biology. It 
is hoped that this shift in current approach that has led to the creation of the Athlome 
Project Consortium and ideas brought forth in this series will encourage a new standard 
of excellence and motivate more international collaboration in sport and exercise 
genomics.  
 
References 
1. Berman, Y, North, KN. A gene for speed: the emerging role of alpha-actinin-3 in 
muscle metabolism. Physiology (Bethesda)  25: 250-259, 2010.  
2. Bouchard, C. Genomic predictors of trainability. Exp Physiol  97: 347-352, 2012.  
3. Bouchard, C. Exercise genomics-a paradigm shift is needed: a commentary. Br J 
Sports Med  49: 1492-1496, 2015.  
4. Bramble, DM, Lieberman, DE. Endurance running and the evolution of Homo. 
Nature  432: 345-352, 2004.  
5.  Catalogue of somatic mutations in cancer. Retrieved 13/01/2016, from 
http://cancer.sanger.ac.uk 
6. Durussel, J, Haile, DW, Mooses, K, Daskalaki, E, Beattie, W, Mooses, M, 
Mekonen, W, Ongaro, N, Anjila, E, Patel, RK, Padmanabhan, N, McBride, MW, 
McClure, JD, Pitsiladis, YP. The blood transcriptional signature of recombinant 
human erythropoietin administration and implications for anti-doping strategies. Physiol 
Genomics (January 12, 2016), doi: 10.1152/physiolgenomics.00108.2015 
7. Forbes, SA, Beare, D, Gunasekaran, P, Leung, K, Bindal, N, Boutselakis, H, 
Ding, M, Bamford, S, Cole, C, Ward, S, Kok, CY, Jia, M, De, T, Teague, JW, 
Stratton, MR, McDermott, U, Campbell, PJ. COSMIC: exploring the world's 
knowledge of somatic mutations in human cancer. Nucleic Acids Res  43: D805-811, 
2015.  
8. MacArthur, DG, Seto, JT, Raftery, JM, Quinlan, KG, Huttley, GA, Hook, JW, 
Lemckert, FA, Kee, AJ, Edwards, MR, Berman, Y, Hardeman, EC, Gunning, PW, 
Easteal, S, Yang, N, North, KN. Loss of ACTN3 gene function alters mouse muscle 
metabolism and shows evidence of positive selection in humans. Nat Genet  39: 
1261-1265, 2007.  
9. National Human Genome Research Institute (NHGRI) Clinical Sequencing 
Exploratory Research (CSER) The MedSeq Project: Integration of Whole Genome 
Sequencing into Clinical Medicine (HG006500). Retrieved 13/01/2016, from 
http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000958.v1.p1 
10. Pitsiladis, YP, Tanaka, M, Eynon, N, Bouchard, C, North, KN, Williams, AG, 
Collins, M, Moran, CN, Britton, SL, Fuku, N, Ashley, EA, Klissouras, V, Lucia, A, 
Ahmetov, II, de Geus, EJ, Alsayrafi, M. The Athlome Project Consortium: A 
Concerted Effort to Discover Genomic and other "OMIC" Markers of Athletic 
Performance. Physiol Genomics (December 29, 2015), doi: 
10.1152/physiolgenomics.00105.2015 
11. Puthucheary, Z, Skipworth, JR, Rawal, J, Loosemore, M, Van Someren, K, 
Montgomery, HE. The ACE gene and human performance: 12 years on. Sports Med  
41: 433-448, 2011.  
12. Ruxton, GD, Wilkinson, DM. Endurance running and its relevance to scavenging 
by early hominins. Evolution  67: 861-867, 2013.  
13. Sham, PC, Purcell, SM. Statistical power and significance testing in large-scale 
genetic studies. Nat Rev Genet  15: 335-346, 2014.  
14. Tanisawa, K, Ito, T, Sun, X, Cao, ZB, Sakamoto, S, Tanaka, M, Higuchi, M. 
Polygenic risk for hypertriglyceridemia is attenuated in Japanese men with high fitness 
levels. Physiol Genomics  46: 207-215, 2014.  
15. Tanisawa, K, Ito, T, Sun, X, Ise, R, Oshima, S, Cao, ZB, Sakamoto, S, Tanaka, 
M, Higuchi, M. Strong influence of dietary intake and physical activity on body fatness 
in elderly Japanese men: age-associated loss of polygenic resistance against obesity. 
Genes Nutr  9: 416, 2014.  
16. Tanisawa, K, Ito, T, Sun, X, Ise, R, Oshima, S, Cao, ZB, Sakamoto, S, Tanaka, 
M, Higuchi, M. High cardiorespiratory fitness can reduce glycated hemoglobin levels 
regardless of polygenic risk for Type 2 diabetes mellitus in nondiabetic Japanese men. 
Physiol Genomics  46: 497-504, 2014.  
17. Williams, AG, Folland, JP. Similarity of polygenic profiles for elite human 
physical performance. J Physiol  586: 113-121, 2008.  
18. Zimran, A, Gelbart, T, Westwood, B, Grabowski, GA, Beutler, E. High 
frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews. 
Am J Hum Genet  49: 855-859, 1991.  
 
 
